- Home
- Publications
- Publication Search
- Publication Details
Title
Role of epigenetic modifications in luminal breast cancer
Authors
Keywords
-
Journal
Epigenomics
Volume 7, Issue 5, Pages 847-862
Publisher
Future Medicine Ltd
Online
2015-02-18
DOI
10.2217/epi.15.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy.
- (2017) A. M. Wardley et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of panobinostat (LBH589) with capecitabine with or without lapatinib.
- (2017) N. W. Peacock et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors
- (2014) Jimin Woo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
- (2014) Suzanne A. W. Fuqua et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer
- (2014) Mei-Yi Wu et al. CANCER LETTERS
- Correction: De Novo Peptide Design and Experimental Validation of Histone Methyltransferase Inhibitors
- (2014) PLoS One
- Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
- (2014) T. N. Pathiraja et al. Science Translational Medicine
- Rational design and validation of a Tip60 histone acetyltransferase inhibitor
- (2014) Chunxia Gao et al. Scientific Reports
- Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells
- (2013) Ziyan Lu et al. ANTI-CANCER DRUGS
- Genetic and epigenetic analysis of putative breast cancer stem cell models
- (2013) Marija Balic et al. BMC CANCER
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
- (2013) Aleix Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of MicroRNAs in Breast Cancer Stem Cells
- (2013) Daniela Schwarzenbacher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2
- (2013) G. J. Sabnis et al. MOLECULAR CANCER THERAPEUTICS
- Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer
- (2013) Andrew Stone et al. Epigenomics
- A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma
- (2012) Yuan Yuan et al. ACS Chemical Biology
- Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer
- (2012) Charles Marson Anti-Cancer Agents in Medicinal Chemistry
- Epigenetics of estrogen receptor-negative primary breast cancer
- (2012) Kelly T Huynh et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
- (2012) Rocío García-Becerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer
- (2012) Chenfang Dong et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of epigenetic regulation in stem cell and cancer biology
- (2012) Lilian E. van Vlerken et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition
- (2012) Sharmila Shankar et al. PHARMACOLOGY & THERAPEUTICS
- Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression
- (2012) Jong Hun Lee et al. PHARMACOLOGY & THERAPEUTICS
- EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
- (2012) Lilian E. van Vlerken et al. Stem Cells Translational Medicine
- Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells
- (2011) Qingsong Zhu et al. AMINO ACIDS
- The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
- (2011) J. Zhou et al. BLOOD
- Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
- (2011) B. Ramaswamy et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
- (2011) Steven A. Belinsky et al. CANCER RESEARCH
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- Epigenetic Events Associated with Breast Cancer and Their Prevention by Dietary Components Targeting the Epigenome
- (2011) Shabana I. Khan et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients
- (2011) T. N. Pathiraja et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cells and Chemosensitivity
- (2011) M. Maugeri-Sacca et al. CLINICAL CANCER RESEARCH
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
- (2011) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
- (2011) Hong Yin et al. PLoS One
- Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
- (2011) Sanjit K. Roy et al. PLoS One
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
- (2011) F. Fang et al. Science Translational Medicine
- Epigenetic Regulation of Cell Type–Specific Expression Patterns in the Human Mammary Epithelium
- (2011) Reo Maruyama et al. PLoS Genetics
- DNA methyltransferases and methyl-binding proteins of mammals
- (2010) J. Lan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
- (2010) Victoria Wargon et al. BREAST CANCER RESEARCH AND TREATMENT
- H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM
- (2010) M.-W. Chen et al. CANCER RESEARCH
- Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor in Breast Cancer Cells
- (2010) P. de Souza Rocha Simonini et al. CANCER RESEARCH
- A MicroRNA Targeting Dicer for Metastasis Control
- (2010) Graziano Martello et al. CELL
- Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells
- (2010) Barbara Stefanska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples
- (2010) Jianhua Xiong et al. FEBS Journal
- Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β
- (2010) Hanning You et al. HEPATOLOGY
- G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53
- (2010) Jing Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer—Role in Treatment Response
- (2010) Thushangi N. Pathiraja et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Clinical significance of Polycomb gene expression in brain tumors
- (2010) Francesco Crea et al. Molecular Cancer
- Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach
- (2010) Jose L. Medina-Franco et al. MOLECULAR DIVERSITY
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- Epigenetic modifications and human pathologies: cancer and CVD
- (2010) Susan J. Duthie PROCEEDINGS OF THE NUTRITION SOCIETY
- Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment
- (2010) Marie-Hélène Teiten et al. Toxins
- Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
- (2009) Madhavi Billam et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
- (2009) M. M. Gaudet et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
- (2009) Soyoung Lim et al. CARCINOGENESIS
- TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation
- (2009) Inha Heo et al. CELL
- Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells
- (2009) Xue-Gang Luo et al. IUBMB LIFE
- Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
- (2009) Jie Yang et al. MEDICAL ONCOLOGY
- FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol
- (2009) Rakesh K. Srivastava et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells
- (2009) D. Iliopoulos et al. Science Signaling
- Curcumin is a potent DNA hypomethylation agent
- (2008) Zhongfa Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
- (2008) Victoria Wargon et al. BREAST CANCER RESEARCH AND TREATMENT
- Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
- (2008) J. M. Yi et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Promoter hypomethylation regulates CD133 expression in human gliomas
- (2008) Kouichi Tabu et al. CELL RESEARCH
- Promoter CpG Methylation Contributes to ES Cell Gene Regulation in Parallel with Oct4/Nanog, PcG Complex, and Histone H3 K4/K27 Trimethylation
- (2008) Shaun D. Fouse et al. Cell Stem Cell
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
- (2008) Jiang Fan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells
- (2008) Yutaka Kondo et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started